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Abstract
Olfactory ensheathing cells (OECs) represent an interesting candidate for cell therapy and could be obtained from
olfactory mucosa (OM-OECs) or olfactory bulbs (OB-OECs). Recent reports suggest that, depending on their origin, OECs
display different functional properties. We show here the complementary and additive effects of co-transplanting OM-
OECs and OB-OECs after lesion of a peripheral nerve. For this, a selective motor denervation of the laryngeal muscles was
performed by a section/anastomosis of the recurrent laryngeal nerve (RLN). Two months after surgery, recovery of the
laryngeal movements and synkinesis phenonema were analyzed by videolaryngoscopy. To complete these assessments,
measure of latency and potential duration were determined by electrophysiological recordings and myelinated nerve fiber
profiles were defined based on toluidine blue staining. To explain some of the mechanisms involved, tracking of GFP
positive OECs was performed. It appears that transplantation of OM-OECs or OB-OECs displayed opposite abilities to
improve functional recovery. Indeed, OM-OECs increased recuperation of laryngeal muscles activities without appropriate
functional recovery. In contrast, OB-OECs induced some functional recovery by enhancing axonal regrowth. Importantly,
co-transplantation of OM-OECs and OB-OECs supported a major functional recovery, with reduction of synkinesis
phenomena. This study is the first which clearly demonstrates the complementary and additive properties of OECs
obtained from olfactory mucosa and olfactory bulb to improve functional recovery after transplantation in a nerve lesion
model.
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Introduction
Olfactory ensheathing cells (OECs) are specialized glial cells
that guide the regeneration of non-myelinated olfactory axons
from the peripheral nasal epithelium through the cribriform plate
of the ethmoid bone and into the olfactory bulb (OB) [1,2].
Several studies have demonstrated the great potential of OECs to
improve functional recovery and axonal regrowth after lesions of
the CNS or PNS [3,4,5]. The source of OECs dramatically
influences the success of cellular transplantation. In fact, it seems
that OECs from OB and OM are specialized in different
physiological processes [6,7,8], and have a different behavior
after transplantation in vivo [7]. Recently, we demonstrated in a
vagus nerve (VN) lesion model, that both type of OECs could
improve electrical muscular activity and nervous conduction, but
that OM-OECs induce aberrant movements, whereas OB-OECs
increase functional recovery [9]. It appears too, that OM-OECs
enhance tissue healing and reduce fibrosis. These two specific
abilities could be crucial to improve recovery after lesion of the
nervous system.
We report herein additive effects of co-injected OECs from OB
and OM on selective reinnervation of laryngeal muscles after a
section/anastomosis of the recurrent laryngeal nerve.
Materials and Methods
Animals
Experiments were performed at the Laboratory of Experimental
Surgery, Faculty of Medicine, Rouen, France (University license:
B76-450-05, surgeon license: 76.A.21), after acceptance by the
Ethical Committee for Animal Experiments in Normandy: N/01-
01- 10/01/01-13. All surgery was performed under ketamine
hydrochloride and chlorpromazine hydrochloride anesthesia, all
efforts were made to minimize suffering.
For this study Fischer inbred rats were used (Charles River,
L’Arbresle, France).
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(Reseaumatique, Bernay, France).
Cell culture
Olfactory bulb and olfactory mucosa primary cultures were
prepared as described previously by our team [8]. Briefly, rats were
deeply anesthetized (isofluorane) and decapitated. OB were imme-
diately dissected and placed in Hank’s buffered salt solution (H.B.S.S,
Invitrogen, Carlsbad, CA), after removing the meninges. H.B.S.S
containing 0.1% trypsin (Invitrogen) and OB were incubated for
45 min at 37uC. Trypsinization was stopped by adding Dulbecco’s
Modified Eagle’s/Ham’s F12 medium (D.M.E.M/F12, Invitrogen),
supplemented with 10% Fetal Bovine Serum (F.B.S, Invitrogen) and
1% penicillin/streptomycin (Invitrogen) (DF-10S). The tissue was
centrifuged at 1.000 RPM for 3 min, resuspended in DF-10S and
centrifuged again. Tissue was then triturated in 2 ml DF-10S using a
micropipette, until an homogenous cell suspension was obtained.
Cells were plated in DF-10S in 75 cm
2 flasks (TPP, Trasadingen,
Switzerland), pre-coated with poly-L-Lysine (50 mg/mL). The flasks
were incubated at 37uC, 5% CO2. The medium was changed
every two days. Eight days after plating, OB primary cultures were
confluent.
In the same rats, the nasal cavity was opened sagittally with a
spatula and OM was cut into small pieces. After a short rinse in
H.B.S.S, samples were trypsinized (1% trypsin for 45 min at 37uC)
(Invitrogen). The OM is easily identified in the rat by its posterior
position on the nasal septum and by the yellowish appearance of
the epithelial surface.
Then, samples were cultivated with the same protocol that for
OB cultures [10].
Cultures were checked for OECs by immunocytochemistry and
flow-cytometry, as previously described [8]. These analyses per-
mitted to determinate that after eight days in vitro OB cultures
contained approximately 50% of p75 positive cells, whereas in the
same time OM cultures contained about 10% of p75 positive cells.
Preparation of the cells for grafting. Before transplanta-
tion, cultures were trypsinized to remove them from the dishes,
and the cells were counted using a hemocytometer. OB and OM
cultures cells were resuspended in a 30:60 (v/v) solution of
DMEM/F-12:Matrigel (BD Biosciences, San Jose, CA.) imme-
diately before grafting. Each animal received a total of 6610
5
OECs for transplantation.
Experimental nerve lesion and cell transplantation
procedure
For experimental groups, adult male Fischer inbred rats (225–
250 g) were used.
All the rats were anesthetized by intraperitoneal injection of
ketamine hydrochloride (12.5 mg/kg) and chlorpromazine hydro-
chloride (0.625 mg/kg).
Five groups were classified as follows:
Group 1 (n=10): sham control group, the right recurrent
laryngeal nerve (RLN) was only surgically exposed, but not
injured.
Group 2 (n=10): the RLN was sectioned and sutured without
treatment (reinnervated control group).
For the groups 3 (n=10), 4 (n=10) and 5 (n=10), the right
RLN was exposed and cut at the level of the seventh tracheal ring.
Then, anastomosis was done by one point of 11.0 wire (Ethicon,
Somerville, NJ) under microscopic control (Zeiss, Oberkochen,
Germany). This surgery constituted a selective motor denervation
of the laryngeal muscles, RLN is a mixed nerve.
For these groups, using a micropipette, 90 ml DMEM/
F-12:Matrigel (30:60) containing 6610
6 cells (6610
5 OECs) of
OM origin (group 3: reinnervated-OM treated group) or 1.2610
6
cells (6610
5 OECs) of OB origin (group 4: reinnervated-OB
treated group), or a mixture of 6610
5 cells of OB origin (3610
5
OECs) and 3610
6 cells of OM origin (3610
5 OECs) (group 5:
reinnervated-OM+OB treated group) cultures was laid over the
section/anastomosis site, immediately at the time of surgery. The
same numbers of OECs was injected in all the treated groups.
Matrigel was used for cellular transplantation because when
incubated at 37uC (body temperature), the Matrigel proteins self-
assemble producing a thin film which permits to retain OECs on
site of injection. Care was taken that Matrigel containing OECs
was self-assembled on anastomosed nerve before muscle and skin
were closed. To this manner, 2 cm of RLN were recovered by
Matrigel.
After surgery, all the rats were caged individually under a heat
lamp during 24 hours.
Before and after the experiments, rats were kept on standard
laboratory food and tap water ad libitum, with an artificial
12 hours light/dark cycle.
Evaluation
Evaluations were performed 2 months after surgery, under
spontaneous ventilation, on 10 rats of each group. All the
investigations were performed blindly.
Videolaryngoscopy. The videolaryngoscopic evaluation was
performed as previously described, in using a video camera
(Telecam SL NLSC 20212120, Karl Storz Endoskope) [9].
The 30u laryngoscope (Karl Storz GmbH & Co. KG,
Tuttlingen, Germany) was inserted orally and adjusted to provide
the best view of the larynx. Anatomic landmarks were determined
to reproduce the same view for each recording [11].
Three sequences of two glottal frames were selected for each rat,
consisting in the images of successive maximal adduction and
maximal abduction. For each sequence absolute angular differ-
ences was measured between movement of maximal abduction
(Figure S1A) and maximal adduction (Figure S1B) for the right
vocal cord.
To complete the analysis of the angular difference by dynamic
measure, the vocal cords movement during inspiration was scored.
Dynamic score was based on movement amplitude. In terms of
amplitude, for each recording, we scored 0 for no movement, 1 for
minimal amplitude of movement, 2 for important amplitude of
movement with a total adduction and 3 for normal amplitude of
movement.
To complete this measurement, in order to score the functional
recovery of larynx, synkinesis and paradoxal movements were
observed. For this, in using another scale in which all paradoxal
movements were scored with 0, functional recovery was performed.
In terms of function, for each recording, we scored 0 for no or
paradoxal movement, 1 for a minimal functional movement, 2 for
an important functional movement and 3 for a total recuperation of
laryngeal function [12].
For these purposes, comparison to the healthy side served as
reference.
Electromyography (EMG). The electrophysiological evalua-
fotion was performed as previously described [9]. Anesthetized rat
was placed in a dorsal decubitus position, and a median incision
was made to expose the larynx. To record the right posterior
cricoarytenoid muscle (PCA) activity, a monopolar needle
electrode (3860.45 mm) (AMBU, Gouda, Netherlands) was
introduced in the PCA, after an incision of the cricothyroid
membrane. Samplings were displayed on an EMG recorder
(Electromyogram Keypoint, Dantec Dynamics, Bristol, UK).
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analyzed in terms of richness and synchronization with respiration.
Then, the right VN was dissected and stimulated during 0.1 ms
with a progressive increase of the intensity. The electrical response
in the PCA muscle was recorded and latency and potential
duration were measured for the supramaximal amplitude of
stimulation.
VN was chosen for site of stimulation, because the size of the
RLN could not permit to position the stimulator without inducing
nerve lesion.
Morphometric analysis for axonal counting. For this
evaluation, rats were euthanized (overdose of pentobarbital), then,
RLN was sectioned and removed.
The distal portions of the RLN were fixed, blocked, and
embedded as previously described by Roglio et al. [13].
Then, semi-thin transverse sections (1 mm-thick) were cut using
a Pyramitome Ultramicrotomy System (Ultracut S, Reichert/
Leica, Solms, Germany) and stained by 0.1% Toluidine Blue in
1% sodium tetraborate (Merck, Darmstadt, Germany) for 75 s at
70uC.
The total number of fibers was counted in the RLN
(magnification: 6630) by use of an image analysis system
(Mercator, Explora Nova, La Rochelle, France).
In each RLN, myelinated nerve fiber profiles were counted and
measured by determining the outer and inner boundary of the
myelin sheath using the automatic threshold tool. For each RLN,
the total number of fibers, the mean size of fibers and the myelin
thickness were determinated.
GFP labeling of transplanted cells. This evaluation was
performed in 2 others rats for each treated group (reinervated-OB
treated and reinnervated-OM treated groups), to determine if the
cells injected act in penetrating into the RLN.
Briefly, five days before transplantation, OB and OM cultures
were infected with a lentiviral vector harboring enhanced GFP
(multiplicity of infection: 20, time of exposure overnight). Also,
GFP positive cells were injected as previously described in
‘‘materials and methods’’.
Three weeks after transplantation of GFP positive cells, rats
were euthanized (overdose of pentobarbital), RLN were removed
and cryo-conserved (frozen with liquid nitrogen and stored at
280uc). Then, fifteen micrometers sections were coverslipped with
mounting media (VectaShield, Vector Laboratories, Burlingame,
CA.) and were examined under fluorescent microscope (6100)
(Zeiss, Axioscope). Twenty consecutive longitudinal sections were
examined for each RLN. For interpretation, fluorescence was
compared to control RLN (left RLN no transplanted with GFP
positive cells).
Statistics
PrismH software (Graphpad Software, La Jolla, CA.) was used
for statistics. All data were presented as means 6 SEM. One way
ANOVA was used, followed by a Tukey’s test, to identify
differences between the groups. A p value of ,0.05 was considered
statistically significant.
Results
Two months after surgery, videolaryngoscopy, EMG recordings
and morphometric analysis were performed blindly in ten rats for
each group.
General observations
In agreement with in our previous observations [9], two months
after surgery, animals that had received transplantation of OM
cultures (OM and OM+OB treated groups) presented a very slight
fibrosis in comparison to the other groups with or without cellular
transplantation (not shown).
Videolaryngoscopy
Two months after surgery, angular measure, amplitude and
functionality of movements were assessed.
Angular measurement and dynamic movement score showed
that the reinnervated control group (1.9061.38u) displayed a
significant reduction of movement in comparison with the control
group (20.6661.67u)( p ,0.001) (Fig. 1A and 1B). Transplantation
of OECs from the mucosa or from the olfactory bulb improves
significantly movements of the vocal cords (Fig. 1A and 1B). The
reinnervated-OM treated group showed a significant augmenta-
tion of the angular movement (6.8363.96u)( p ,0.05) and a
significant improvement of the dynamic score in comparison to the
reinnervated control group (p,0.05) (Fig. 1A and 1B). Trans-
plantation of OECs from OB increased significantly the angular
measure (8.5763.46u) (0.01,p,0.001) and the dynamic score in
comparison to the reinnervated control group (0.01,p,0.001)
(Fig. 1A and 1B). Analysis of angular measure and dynamic
movement evidenced a great potential recovery of co-transplan-
tation of OECs from OM and OB cultures. Indeed, the
reinnervated-OM+OB treated group showed a significant aug-
mentation of the angular movement of the vocal cords
(10.9563.50u) (0.01,p,0.001) and a very significant improve-
ment of the dynamic score (p,0.001) in comparison to the
reinnervated control group. Moreover, co-transplantation of
OECs from OM+OB improved significantly the dynamic score
and the angular movement in comparison to the reinnervated-OM
treated group (0.01,p,0.001).
To complete these measurements, using a scale based on the
functional recovery, parodoxical movements were analyzed. This
analysis revealed that transplantation of OECs from OB improved
functional recovery in comparison to the reinnervated control and
reinnervated-OM treated (p,0.05) groups and that animals which
received OECs obtained from OM did not show any functional
recovery in comparison with reinnervated control group (Fig. 1C).
This analysis showed also, that co-transplantation of OECs from
OM+OB improved very significantly functional recovery in
comparison to the reinnervated control (p,0.001) and reinner-
vated-OM treated groups (p,0.001). Furthermore, the reinner-
vated-OM+OB treated group presented a significant improvement
of functional recovery in comparison to the reinnervated-OB
treated group (p,0.05).
For all measurements, control (sham) group presented signifi-
cantly better movements (angular movements, dynamic and
functional scores) in comparison with all the reinnervated groups
(p,0.001).
Electromyography
Animals of the sham group presented a typically rich electrical
muscular activity. This muscular activity was improved during
inspiration showing a synchronization of the laryngeal muscles
with respiratory cycles (Fig. 2A).
Analysis of the EMG traces showed that cellular transplantation
of OECs (from OM, OB and OM+OB) improved electrical
activities of the laryngeal muscles in comparison with the
reinnervated control group (Fig. 2C, 2D and 2E), in particular
the traces presented an augmentation of the electrical muscular
activity during inspiration phases whereas reinnervated control
animals left this synchronized activities (Fig. 2B).
Typical traces of the different groups are presented in Fig. 2.
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latency (Fig. 3A) and potential duration (Fig. 3B). Measure of
latency permits to determinate the time that nerve takes to conduct
electrical stimulation and measure of potential duration gives
information about homogeneity of the nervous conduction in
determinating the time during which laryngeal muscles received
the electrical stimulation.
Analysis of latencies, in this model of section/anastomosis of
the RLN, showed that there is no difference between the
different groups, probably due to the small distance between site
of denervation and muscular effectors (Fig. 3A). In the same
time, potential duration was significantly increased in reinner-
vated control group (4.5361.02 ms), with a polyphasic trace
( F i g .3 D ) ,i nc o m p a r i s o nt ot h ec o n t r o lg r o u p( 2 . 2 8 60.27 ms)
(p,0.001).Transplantation of OECs from OM (3.7460.37 ms),
OB (3.1560.46 ms) and OM+OB (2.6560.31 ms) permitted to
reduce potential duration in comparison to the reinnervated
control group (4.5361.02 ms), with a significant reduction for
transplanted groups with OECs from OB (p,0.05) and co-
transplanted with OECs from OM+OB (0.01,p,0.001)
(Fig. 3B). Reinnervated-OM treated group showed a reduction
of potential duration in comparison to the reinnervated control
group (p=0.13) with no significant differences, but traces
presented also a polyphasic response (Fig. 3E). In contrast,
reinnervated-OB treated group showed a reduction of potential
duration in comparison to reinnervated-OM treated group
(p=0.13) with no significant differences and in this group,
responses presented monophasic profile (Fig. 3F), as observed in
control group (Fig. 3C). Reinnervated-OM+OB treated group
showed a significant reduction of potential duration in
comparison to the reinnervated-OM treated group (0.01,p,
0.001), with typical monophasic trace (Fig. 3G) and showed a
reduction of potential duration with no significant differences
(p=0.10) in comparison with reinnervated-OB treated group.
Morphometric analysis for axonal counting
The morphological analysis was performed two months after
surgery on the distal part of the RLN. At this time, the total
number of fibers, the mean size of fibers and the myelin thickness
were determinated. The analysis of the numbers of myelinated
fibers showed that there is no difference between all the treated
groups and that all these groups presented a significant reduction
of the numbers of fibers in comparison to the control group
(p,0.001) (Fig. 4A).
Interestingly, analysis of the mean size of the fibers and the mean
size of the myelin thickness showed that transplantation of OECs
from OB and co-transplantation of OECs from OM+OB improved
significantly these parameters. In fact, the reinnervated-OB treated
group (5.1161.34 mm) showed a significant augmentation of the
mean size of the fibers in comparison to the reinnervated control
group(3.5460.82 mm)(0.01,p,0.001)andincomparisonwiththe
reinnervated-OM treated group (3.4560.81 mm) (0.01,p,0.001)
(Fig. 4B). Reinnervated-OB treated group (0.7260.18 mm) showed
also an augmentation of the mean size of the myelin thickness in
comparison to the reinnervated control (0.4960.15 mm) (p,0.05)
and reinnervated-OM treated group (0.4660.23 mm) (p,0.05)
(Fig. 4C). Co-transplantation of OECs from OM and OB permitted
also to significantly improve the mean size of fibers (5.2160.75 mm)
in comparison to reinnervated control and reinnervated-OM
treated groups (0.01,p,0.001) (Fig.4B), and the mean size of the
myelin thickness (0.7560.25 mm) in comparison to these groups
(p,0.05) (Fig. 4C).
In summary, transplantation of OECs from OB resulted in an
enhancement of size of the fibers and the thickness of the myelin in
comparison to the reinnervated control and reinnervated-OM
treated groups, with no additive effects in case of co-transplanta-
tion of OB+OM OECs. Thus, transplantation of OB-OECs alone
appears responsible for the observed beneficial effects on axonal
regrowth.
Figure 1. Analysis of dynamic, angular movement and functional recovery. Two months after surgery, videolaryngoscopy analysis
permitted to observe an increase in dynamic movement (A) and angular measure (B) in presence of cellular transplantation (OM, OB and OM+OB
cultures) in comparison to reinnervated control group. This analysis permitted also to observe an increase in functional recovery (C) in presence of OB
and OM+OB cultures in comparison to reinnervated control and reinnervated-OM treated groups, and that co-transplanted OECs (OM+OB) permit to
enhance, significantly, functional recovery in comparison to OB-treated group. Data are presented as mean6SEM. Statistical evaluations were based
on one way ANOVA test, (*P,0.05, **0.01,P,0.001, ***P,0.001).
doi:10.1371/journal.pone.0022816.g001
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reinnervated control (Fig. 4E), reinnervated-OM (Fig. 4F), rein-
nervated-OB (Fig. 4G) and reinnervated-OM+OB (Fig. 4H)
treated groups.
GFP labeling of transplanted cells
Three weeks after OB-GFP cells (n=2) and OM-GFP cells
(n=2) transplantation, the right RLN was removed and twenty
consecutive sections of fifteen micrometers were performed and
examined under fluorescent microscope. It appeared, as previously
described by our laboratory [9,14], that any GFP positive cells
could be observed into the nerve which received cellular
transplantation. For observation, RLN control was used. Typical
observations were presented for RLN transplanted with GFP
positive cells (injection around the nerve, in matrigel) (Figure S2A)
and compared with sciatic nerve transplanted (intra-nervous
injection) with GFP positive cells (Figure S2B; taken from material
published in [14]).
Discussion
To our knowledge, this is the first reported study which presents
co-transplantation of the two sub-populations of OECs after nerve
lesion. Also, this study confirms our previous results regarding the
different abilities that could be played by OECs originating from
OB and OM [8,9].
The co-transplantation model presented here demonstrates the
complementary effects played by OM-OECs and OB-OECs.
These two populations of glial cells injected separately improve
vocal cord movements and electrical activity of the laryngeal
muscles, with an effect on fibrosis associated with aberrant
movements in the case of OM-OECs transplantation and an
improvement on axonal regrowth associated with a partial
functional recovery in the case of OB-OECs transplantation. At
the same time, co-transplantation of OM-OECs and OB-OECs
permits, not only to conserve their specific characteristics, but also
permits to enhance abilities of each sub population. Indeed, the
co-transplanted group presents an impressive functional recovery
of the vocal cords movements.
The choice was made to inject OECs with their specific
microenvironment due to the main role of this described elsewhere.
Indeed, others researchers report the presence of olfactory nerve
fibroblasts, which them OECs are closely associated in vivo,a s
casting for effective transplants [15,16,17]. Nevertheless, it could be
excluded that a part of the effects described here may be due to
contaminating cells. Differences in culture conditions might explain
some contradictory results, even by our team, that could be
observed after OECs transplantation [3,18].
In this study, we chose a laryngeal model for the evaluation
because this model permits to score the functionality of the
regeneration, based on the observation of aberrant movements
and synkinesis. In fact, section/anastomosis of the recurrent nerve
Figure 2. Examples of EMG traces obtained during inspiratory effort in posterior cricoarytenoid muscle. Animals of the sham group
presented a typical rich electrical muscular activity, with an increase during inspiration (A). EMG traces showed that cellular transplantation of OECs
from OM (C), OB (D) and OM+OB (E) improved electrical activities of the laryngeal muscles in comparison to the reinnervated control group (B). In
particular, the traces presented an augmentation of the electrical muscular activity during inspiration phases whereas reinnervated control animals
left this synchronized activities.
doi:10.1371/journal.pone.0022816.g002
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muscular co-contraction phenomena [12]. Moreover, lesion of the
recurrent nerve was specifically chosen because this model permits
to perform a selective motor denervation of the laryngeal muscles,
RLN is a mixed nerve. It also permits evaluation at an early stage
(two months) in comparison to the vagus nerve lesion model (three
months), due to the short distance between the denervation site
and muscular targets (7 mm). In our study, an injection around the
sutured nerve was chosen because the size of the RLN does not
permit an intra-nervous injection of the cellular solution.
Finally, it appears that, as previously described, no GFP positive
cell could be found into the anastomosed RLN, indicating that
OM-OECs and OB-OECs exert their specific effect in interacting
with microenvironment but not in penetrating into the severed
nerve [9,14]. In fact, in our model, RLN size did not permit an
injection into the nerve, that’s why cellular cultures were laid over
the section/anastomosis site.
Therapies based on the use of OECs have been widely studied
in many nerve lesion situations [3,5,19,20,21], in particular to
treat spinal cord or peripheral nerve injuries. Recently, it was
discovered that OECs are neural crest cells and share a common
developmental heritage with Schwann cells. This could explain the
great ability of these cells to enhance recovery after transplantation
in PNS [22,23,24]. However, knowledge about these unique glial
cells remains imperfect and it is important to well define properties
of these prior to clinical use. For this purpose, the use of OECs
obtained from OM seems to be the only acceptable source.
However, despite the fact that, OB-OECs and OM-OECs express
the same phenotypic markers in vitro [25], it seems that they do not
have the same ability to migrate and interact with microenviron-
ment after transplantation in vivo [7]. Our recent studies have
clearly demonstrated that these two sub-populations of OECs are
specifically involved in differential physiological processes both in
vitro [8] and in vivo [9].
OM-OECs express typical biological properties. In particular,
OM-OECs could improve recovery by regulation of inflammatory
responses and extracellular matrix formation as well as an increase
in angiogenesis [26]. However, as previously described, by other
reported studies, it seems that these cells have no specific ability to
improve axonal regrowth [27,28,29]. In contrast, OB-OECs exert
Figure 3. Measure of latency and potential duration. Two months after surgery, analysis of the latency after stimulation showed no difference
between the treated groups and the control group (A). Potential duration was also measured and showed that reinnervated control group displayed
a significant longer potential duration in comparison to sham group (B). This analysis permitted, also, to determinate that treated groups showed a
reduction in potential duration in comparison to the reinnervated control group (B), in particular reinnervated-OB and reinnervated-OM+OB treated
groups showed a significant reduction of potential duration with a monophasic response after stimulation (F and G). See figure 1 for statistical
analysis. Typical observations was presented for the control (C), reinnervated control (d), reinnervated-OM (E), reinnervated-OB (F), reinnervated-
OM+OB treated (G) groups.
doi:10.1371/journal.pone.0022816.g003
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targeted axonal regrowth. These distinct behaviors of OM-OECs
and OB-OECs could be due to their role during neurogenesis of
the primary olfactory neurons. Indeed, as well described by
Windus et al., OECs display typical organization in lamina
propria and in OB, in particular in their opposite relationship with
axons of primary olfactory neurons [6]. OM-OECs seem to
enhance growth of olfactory neurons through lamina propria,
whereas OB-OECs seem, for a part of them, participate to axonal
targeting into olfactory glomeruli [6].
In our study, it appears that these distinct properties could be
complementary to improve functional recovery and axonal
regrowth in cases of peripheral nerve injury. In this co-
transplantation model, each sub-population of OECs preserves
their specificity and could, by an additive effect, enhance
functional recovery. Indeed, co-transplanted animals presented a
slight fibrosis, typical of the main role played by OM-OECs, and
in the same time, these animals showed an increase of the mean
size of the fibers and the myelin thickness, in agreement with the
observations of the OB-treated animals. These distinct abilities
permit to the transplanted animals to present the best results in all
the parameters studied, in particular about functional recovery.
This work underlines the fact that for complete functional
recovery after nerve lesions, further investigations could be
conducted to optimize the abilities of olfactory ensheathing cells.
Supporting Information
Figure S1 These images represent typical endoscopic
views of the rat glottis plan. During evaluations, landmarks
are determined to have the same view for each recording. To this
view we could measure the maximal abduction (A) and the
maximal adduction (B).
(TIF)
Figure S2 Recurrent laryngeal nerve transplanted with
GFP labeled cells (green fluorescence) (A) as compared
with GFP labeled OB-OECs retained at the lesion site
into crushed rat’s sciatic nerve (B; taken from material
published [14]). Magnification 6100.
(TIF)
Figure 4. Histological nervous studies. Analysis of the numbers of the myelinated fibers showed that the control group presented a higher
number of myelinated fibers in comparison to the treated groups, and that there is no difference between these groups (A). Analysis of the mean size
of the fibers, two months after surgery, permitted to determinate, that the transplantation of OB and OM+OB cultures increased significantly the
mean size of the fibers in comparison to the reinnervated control and reinnervated-OM treated groups (B). Analysis of the mean size of the myelin
thickness permitted to show that the augmentation of the mean size of the fibers in reinnervated-OB and reinnervated-OM+OB was correlated to an
augmentation of the myelin thickness in these groups in comparison to the reinnervated control and reinnervated-OM treated groups (C). Typical
observations was presented for the control (D), reinnervated control (E), reinnervated-OM (F), reinnervated-OB (G), reinnervated-OM+OB treated (H)
groups (Magnification 6306). See figure 1 for statistical analysis.
doi:10.1371/journal.pone.0022816.g004
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